PH-894: Potent and Specific Silencing of BRD4 in NK CellsMarlborough, Massachusetts--(Newsfile Corp. - October 16, 2024) - Phio Pharmaceuticals Corp.…
Gelclair® is the company's third commercialized prescription productOral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous…
MIAMI, FL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
BRISBANE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical…
Reviewing your Medicare options could save you money MISSION, Kan., Oct. 15, 2024 /PRNewswire/ -- (Family Features) If you're enrolled…
PHILADELPHIA, Oct. 15, 2024 /PRNewswire/ -- The Gabriella Miller Kids First Data Resource Center (Kids First DRC) announces the addition…
Collaboration to Enable Sequencing of Cellular Biopsies ZÜRICH and VIENNA, Oct. 15, 2024 /PRNewswire/ -- Cytosurge AG, a leader in…
The collaboration will enable transformational, proactive care at scale across the largest oncology provider footprint in the United States WEST…
SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024…